Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Avadel Pharmaceuticals (AVDL) Non-Current Deferred Tax Liability (2016)

Historic Non-Current Deferred Tax Liability for Avadel Pharmaceuticals (AVDL) over the last 4 years, with Q1 2016 value amounting to $3.5 million.

  • Avadel Pharmaceuticals' Non-Current Deferred Tax Liability fell 4018.42% to $3.5 million in Q1 2016 from the same period last year, while for Mar 2016 it was $3.5 million, marking a year-over-year decrease of 4018.42%. This contributed to the annual value of $2.8 million for FY2013, which is 8014.15% down from last year.
  • Avadel Pharmaceuticals' Non-Current Deferred Tax Liability amounted to $3.5 million in Q1 2016, which was down 4018.42% from $6.1 million recorded in Q2 2015.
  • Avadel Pharmaceuticals' 5-year Non-Current Deferred Tax Liability high stood at $20.9 million for Q1 2012, and its period low was $2.8 million during Q4 2013.
  • Moreover, its 4-year median value for Non-Current Deferred Tax Liability was $8.3 million (2013), whereas its average is $10.3 million.
  • Data for Avadel Pharmaceuticals' Non-Current Deferred Tax Liability shows a peak YoY increase of 3943.14% (in 2013) and a maximum YoY decrease of 8014.15% (in 2013) over the last 5 years.
  • Quarter analysis of 4 years shows Avadel Pharmaceuticals' Non-Current Deferred Tax Liability stood at $14.1 million in 2012, then plummeted by 80.14% to $2.8 million in 2013, then soared by 116.36% to $6.1 million in 2015, then tumbled by 42.23% to $3.5 million in 2016.
  • Its Non-Current Deferred Tax Liability was $3.5 million in Q1 2016, compared to $6.1 million in Q2 2015 and $5.9 million in Q1 2015.